Cover Image
市場調查報告書

止痛藥與止痛設備全球市場

The Global Market for Pain Management Drugs and Devices

出版商 BCC Research 商品編碼 96391
出版日期 內容資訊 英文 251 pages
訂單完成後即時交付
價格
Back to Top
止痛藥與止痛設備全球市場 The Global Market for Pain Management Drugs and Devices
出版日期: 2017年08月31日 內容資訊: 英文 251 pages
簡介

全球止痛藥、設備市場從2014年的366億美元到2015年約378億美元、預計2020年將擴大到443億美元、2015年到2020年的CAGR預估為3.2%。

本報告針對止痛分類的藥品與設備市場分析、提供業界動向、疼痛治療藥物、市場規模、加入市場主要企業檔案。

第1章 介紹

第2章 摘要

第3章 業界概要

  • 疼痛與疼痛治療歷史
  • 疼痛診斷方法
  • 疼痛治療方法
  • 人口統計與人口高齡化
  • 止痛必要性
  • 偏頭痛控制
  • HIV/HIDS相關疼痛
  • 術後疼痛
  • 兒童疼痛

第4章 業界動向

  • 概要
  • 治療過少的問題
  • 疼痛治療與專家面對的課題
  • 處方藥監測方案
  • 連結照護
  • 藥物引起的便秘預防與遵囑性低落
  • 保健止痛問題
  • 疼痛治療FDA批准規範
  • 疼痛設備FDA批准規範
  • 投藥系統

第5章 疼痛治療

  • 概要
  • 藥品止痛
  • OTC止痛藥:概要
  • 止痛設備
  • 止痛處理:類固醇、內視鏡、螢光透視法
  • 止痛代替法
  • 輔助、止痛代替法開發追蹤調查
  • 止痛服務、組織

第6章 處方止痛市場規模與分析

  • 整體市場
  • 處方止痛藥市場:製品種類分類
  • 麻藥性鎮痛藥
  • 非麻藥性鎮痛藥
  • 抗偏頭痛藥
  • 麻醉藥
  • 其他藥劑等級
  • 加入市場企業
  • 未來市場分析

第7章 止痛設備市場規模與分析

  • 介紹
  • 整體市場
  • 製品分類市場
    • 電氣療法
    • 脊椎刺激設備
    • 其他設備
    • 加入市場企業
    • 未來市場分析

第8章 整體市場摘要

  • 整體市場
  • 製品分類市場
  • 地域分類市場

第9章 業界發展

  • 近年活動、開發時間表
    • 藥品生產線
  • 專利分析
    • 疼痛相關專利數量
    • 主要治療藥劑專利
    • 學名藥企業影響
    • 疼痛設備臨床試驗
    • 疼痛研究的未來
    • 疼痛研究:兒童人口
    • 患者結果調查
    • 主要疼痛相關收購、合併

第10章 企業檔案

  • 止痛藥、設備製造商
    • ABBVIE INC.
    • ASTRAZENECA
    • DEPOMED INC.
    • DJO GLOBAL INC.
    • ELI LILLY & CO.
    • ENDO INTERNATIONAL
    • GLAXOSMITHKLINE
    • 久光製藥
    • JOHNSON & JOHNSON
    • MEDTRONIC INC.
    • NOVARTIS INTERNATIONAL AG
    • PFIZER
    • PURDUE PHARMACEUTICALS LP
    • ST. JUDE MEDICAL INC.

第11章 附錄I:止痛藥製造商、開發商

第12章 附錄II:州政府、連絡方式

第13章 附錄III:美國疼痛學會、團體

第14章 I附錄V:全球團體、組織

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC026F

The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Report Includes

  • An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of product categories, use of products, and the competitive landscape
  • Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations
  • Discussion of new regulatory requirements
  • Comprehensive company profiles of major players in the industry

Report Scope

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies two general segments of pain management:

  • Pharmaceuticals.
  • Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:

  • Narcotic pain management.
  • Non-narcotic pain management.
  • Antimigraine treatments.
  • Anesthetics.
  • Other drugs (including CNS therapies).

The device segment covers several product lines and specifically targets the largest product segments including:

  • Electrotherapy stimulators.
  • Spine stimulators.
  • Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.

Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions.

A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:

  • Enbrel : Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
  • Celebrex : Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.

The report is also evaluated in terms of application, discussing market trends and performance for the following areas:

  • Surgical pain.
  • Orthopedic/musculoskeletal pain.
  • Migraine pain.
  • Fibromyalgia pain.
  • Cancer pain.
  • Neuropathic pain.
  • HIV/AIDS pain.
  • Dental pain.
  • General pain.

Analyst Credentials

MELISSA ELDER is a healthcare market analyst specializing in treatments, medical equipment and devices. As a research analyst for more than 20 years, she also worked in medical training and advanced medical technologies. She holds a B.S. degree in business management and is pursuing an MBA in health care management from California Coast University.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Overview
  • Summary of the Major Markets.
  • Market Trends
  • Undertreatment Issues
  • Professional Pain Treatment Issues
  • Access to Care
  • FDA Requirements for Approval of Pain Therapies
  • Drug Delivery Systems

Chapter 3: Market and Technology Background

  • History of Pain and Pain Treatment
  • The Perception of Pain
  • Types of Pain
    • Acute Pain
    • Chronic Pain
  • Assessment of Pain
    • Subjective
    • Objective
  • How Pain is Diagnosed
  • How Pain is Treated
  • Demographics and Aging Populations
    • Global Demographic Overview
    • Gender and Pain
    • Other Influences Determining How Pain is Felt Among Individuals
  • Pain Management Procedures: Steroids, Endoscopy, Fluoroscopy
  • Alternative Methods of Pain Management
  • Growing Trend in Cannabis Treatment for Pain
  • Physical Pain Treatment Modalities
    • Acupuncture/Acupressure
    • Ice (Cryotherapy)
    • Joint Mobilization
    • Manipulation
    • Massage
    • Traction
    • Radiation Therapy
    • Radio-Frequency Neuroablation, Epiduroscopy
    • Surgery
    • Whirlpool Bath (Thermotherapy)
  • Psychological Pain Therapies
    • Biofeedback
    • Hypnosis
    • Behavior Modification/Operant Conditioning
    • Relaxation and Stress Management Training
    • Imagery
    • Autogenic Training
    • Psychosocial Interventions
    • Distraction and Reframing.
  • Tracking the Development of Complementary and Alternative Pain Control Methods
  • Pain Management Services and Organizations
    • Home Care
    • Hospice
    • Hospitals
    • Pain Clinics
    • Skilled Nursing Facilities

Chapter 4: Industry Trends

  • Overview
    • Undertreatment Issues
    • Treatment of Pain and Issues Facing the Professional Segment
    • Prescription Drug Monitoring Programs
    • Access to Care
    • Managed Care Pain Management Issues
    • FDA Approval of Pain Therapies
    • FDA Approval of Pain Devices
    • Risk Evaluation and Mitigation Strategy (REMS)
    • Acetaminophen and FDA Changes
    • Codeine in Cough and Cold Medications
    • NSAIDs Linked to Increased Risk of Heart Attack or Stroke
    • Drug Delivery Systems

Chapter 5: Treating Pain: Markets by Product Type

  • Overview
  • Pharmaceutical Pain Management
    • Prescription Pain Management Products
    • Total Market
    • Narcotic Analgesics.
    • Non-narcotic Analgesics
    • Antimigraine Agents
    • Anesthetics
    • Other Drug Classes
  • Pain Management Devices
    • Pain Management Device Market
    • Total Market
    • Stimulation Therapy
    • Combination Pain Management Devices

Chapter 6: Market Breakdown by Application

  • Pain Management by Application
    • Surgical Pain Management
    • Orthopedic/Musculoskeletal Pain Management
    • Fibromyalgia Pain
    • Cancer Pain Management
    • Neuropathic Pain
    • HIV/AIDS Related Pain
    • Burn Pain
    • Dental Pain

Chapter 7: Market Breakdown by Region

  • Global Health Indicators
    • Health Expenditures and GDP Review
    • Average Length of Stay
    • Public Healthcare Systems Around the World
  • Markets by Global Region
    • North America
    • Europe, Middle East, Africa (EMEA)
    • Asia-Pacific
    • Latin America

Chapter 8: Industry Developments

  • Timeline of Significant Industry Events and Developments
  • Pharmaceutical Pipeline
  • Pain Device Clinical Trials
  • Patent Analysis
    • Patent Review by Year
    • Patent Review by Type
    • Patent Review by Company
    • Patent Review by Country
    • Patent Review by Assignee.
    • Drug Patents for Selected Therapies
  • The Brand/Generic Market Split
  • Future of Pain Research
    • Pain Research: Pediatric Populations
    • Patient Outcomes Research
    • Selected Pain-related Acquisitions and Alliances

Chapter 9: Analysis of Market Opportunities

  • Total Pain Management Market
    • Markets by Type
    • Markets by Application
    • Markets by Global Region

Chapter 10: Company Profiles

Appendix A: Terminology and Sources of Information

  • Pain Management Pharmaceutical Manufacturers and Developers
  • U.S. Pain Societies and Associations
  • International Associations and Organizations

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for Pain Management, by Major Segment, Through 2022 ($ Millions)
  • Table 1 Objective Signs of Pain
  • Table 2 Global Population Growth, by Select Country, 2015 and 2020 (Millions)
  • Table 3 Global Population Growth, by Age Group, Through 2050 (Millions)
  • Table 4 Global Life Expectancy at Birth, by Select Country, 1980-2020 (Years)
  • Table 5 Pain by Select Category and Gender in the Age 18+ U.S. Population,* 1997-2010 (Thousands)
  • Table 6 U.S. Medical Marijuana Programs, by State
  • Table 7 Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies, 2014 (%)
  • Table 8 Use of Complementary and Alternative Medicine Among U.S. Adults, by Type of Therapy, 2002-2015 (Thousands)
  • Table 9 Percentage of U.S. Hospice Patients, by Gender and Age Group, 2009-2014
  • Table 10 Percentage of Hospice Admissions, by Primary Diagnosis, 2009-2014 (% of Total)
  • Table 11 NHPCO Committees
  • Table 12 Definition of Pain Clinics
  • Table 13 Desirable Characteristics of Pain Clinics, by Type
  • Table 14 Registered Pain Clinics in the United States, by Top Metro Area, 2016 (Number)
  • Table 15 Registered Pain Clinics, by Country (Number)
  • Table 16 Availability of Education in Pain Management, by Select Region/Country
  • Table 17 Agency Responsible for PDMP in Each State
  • Table 18 Benefits of Prescription Monitoring Programs for Medical Boards
  • Table 19 Drugs Monitored by PDMPS, as of June 2017
  • Table 20 States with Electronic Prescription Monitoring Programs, as of June 2017
  • Table 21 Nurse Continuing Education Requirements for Pain Management, by Requiring State
  • Table 22 WHO List of Essential Medicines for Adult Pain Management
  • Table 23 Availability of Injectable Morphine, by Region/Country
  • Table 24 Availability of Oral Morphine in Hospice-Type Settings, by Region/Country
  • Table 25 FDA Analgesia/Anesthesia Drug Shortages, June 2017
  • Table 26 Parts 862-892 of 21 CFR
  • Table 27 List of Extended-Release and Long-Acting Opioid Products Subject to Opioid REMS, by Brand Name Product, May 2017
  • Table 28 List of Extended-Release and Long-Acting Opioid Products Subject to Opioid REMS, by Generic Product, May 2017
  • Table 29 List of Products Subject to the TIRF REMS Access Program, 2011-2016
  • Table 30 List of NSAIDs
  • Table 31 Advantages of Iontophoretic Drug Delivery
  • Table 32 FDA Applications/Approvals, Jan. 2010 Through Jan. 2017
  • Table 33 Global Market for Prescription Pain Management Pharmaceuticals, by Product, Through 2022 ($ Millions)
  • Table 34 Most Commonly Used General Anesthetic Agents
  • Table 35 Global Market for Pain Management Devices, by Technology Type, Through 2022 ($ Millions)
  • Table 36 Global Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 37 Global Market for Surgical Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 38 Birth Rates and Births, by Country, 2016 and 2025 (Thousands)
  • Table 39 Global Market for Orthopedic/Musculoskeletal Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 40 Global Market for Migraine/Headache Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 41 Global Market for Fibromyalgia Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 42 Cancer Pain Medication
  • Table 43 Global Market for Cancer Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 44 Global Market for Neuropathic Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 45 Global Market for HIV/AIDS Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 46 Global Market for Burn Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 47 Global Market for Dental Pain Management, Through 2022 ($ Millions)
  • Table 48 Health Expenditures as a Percentage of GDP, by Select Country, 1980-2015 (%)
  • Table 49 Average Hospital Length of Stay, by Select Country, 1970-2015 (Days)
  • Table 50 World Health Organization Ranking of Healthcare Systems, 2000
  • Table 51 Major Countries, by Region
  • Table 52 Global Market for Pain Management, by Region, Through 2022 ($ Millions)
  • Table 53 North American Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 54 EMEA Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 55 Asia-Pacific Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 56 Latin America Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 57 Select Pain Management Drug Pipelines
  • Table 58 Selected Pain Management Device Trials
  • Table 59 U.S. Patents on Pain Treatments, Issued, by Year, Jan. 2000 Through March 2017 (Number)
  • Table 60 Number of U.S. Patents on Pain Technologies, by Abstract Description
  • Table 61 U.S. Patents on Recent Pain Technologies, March 21, 2017-April 18, 2017
  • Table 62 U.S. Patent Expiration Dates for Select Pain Drugs
  • Table 63 First Time Prescription Generic Pain Management and Approvals, April 2005-June 2017
  • Table 64 Pain or Pain-related Clinical Trials, by Region, 2017
  • Table 65 Market Opportunities for Pain Management Treatments, Through 2022
  • Table 66 Global Market for Pain Management, by Major Type, Through 2022 ($ Millions)
  • Table 67 Global Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 68 Global Market for Pain Management, by Region, Through 2022 ($ Millions)
  • Table 69 Abbott Laboratories Financials, Through 2016 ($ Millions)
  • Table 70 AbbVie Financials, Through 2016 ($ Millions)
  • Table 71 Allergan Financials, Through 2016 ($ Millions)
  • Table 72 AstraZeneca Financials, Through 2016 ($ Millions)
  • Table 73 Boston Scientific Financials, Through 2016 ($ Millions)
  • Table 74 Depomed Financials, Through 2016 ($ Millions)
  • Table 75 DJO Global financials, Through 2016 ($ Millions)
  • Table 76 Eli Lilly & Co. Financials, Through 2016 ($ Millions)
  • Table 77 Endo International Financials, Through 2016 ($ Millions)
  • Table 78 GlaxoSmithKline Financials, Through 2016 ($ Millions)
  • Table 79 Grünenthal Financials, Through 2016 ($ Millions)
  • Table 80 Hisamitsu Pharmaceutical financials, Through Fiscal 2017 ($ Millions)
  • Table 81 Johnson & Johnson Financials, Through 2016 ($ Millions)
  • Table 82 Medtronic Financials, Through Fiscal Year 2016 ($ Millions)
  • Table 83 Novartis Financials, Through 2016 ($ Millions)
  • Table 84 Pfizer Financials, Through 2016 ($ Millions)
  • Table 85 Glossary of terms used in Pain Management Drug and Device Markets
  • Table 86 Pain Management Pharmaceutical Manufacturers and Developers
  • Table 87 U.S. Pain Societies and Associations
  • Table 88 International Associations and Organizations

List of Figures

  • Summary Figure: Global Market for Pain Management, by Major Segment, 2014-2022 ($ Millions)
  • Figure 1 Pain Management Techniques
  • Figure 2 Global Population, by Select Country, 2015 and 2020 (Millions)
  • Figure 3 Global Population Growth, by Age Group, 2000-2050 (Millions)
  • Figure 4 Global Life Expectancy at Birth, 1980-2020 (Years)
  • Figure 5 Pain by Select Category and Gender in the 18+ U.S. Population,* 1997-2010 (%)
  • Figure 6 Use of Complementary and Alternative Medicine Among U.S. Adults, by Type of Therapy, 2002-2015 (Thousands)
  • Figure 7 Annual Number of U.S. Hospice Patients, 2009-2014
  • Figure 8 Percentage of U.S. Hospice Patients, by Gender, 2014 (%)
  • Figure 9 Percentage of U.S. Hospice Patients, by Age Group, 2014 (%)
  • Figure10 Distribution of Causes of Mortality and Potential Need for Palliative Care (Millions)
  • Figure 11 Distribution of Narcotic Drug Consumption, by Country (All Narcotic Types) (%)
  • Figure 12 Distribution of Morphine Consumption by Region/Country, 2015 (%)
  • Figure 13 Obstacles to Availability of Opioids for Medical Needs (Number)
  • Figure 14 Global Market for Prescription Pain Management Pharmaceuticals, by Product, 2014-2022 ($ Millions)
  • Figure 15 Global Market Distribution for Narcotic Analgesics, by Ingredient*, 2017 (%)
  • Figure 16 Global Market Distribution for Non-Narcotic Analgesics, by Ingredient*, 2017 (%)
  • Figure 17 Global Market Distribution for Antimigraine Agents, by Ingredient*, 2017 (%)
  • Figure 18 Global Market Distribution for Anesthetics, by Ingredient*, 2017 (%)
  • Figure 19 Global Market for Pain Management Devices, by Technology Type, 2014-2022 ($ Millions)
  • Figure 20 Global Market for Pain Management, by Application, 2014-2022 ($ Millions)
  • Figure 21 Global Market for Surgical Pain Management, by Product Type, 2014-2022 ($ Millions)
  • Figure 22 Births, by Country, 2016 and 2025
  • Figure 23 Arthritis Impact, Global Prevalence, by Year, 2000-2050
  • Figure 24 Global Cancer Mortality by Select Country per 100,000 Population, 1960-2020
  • Figure 25 Causes of Cancer Pain
  • Figure 26 Burn Pain Management Approach
  • Figure 27 Health Expenditures as a Percentage of GDP, by Select Country, 1980-2015 (%)
  • Figure 28 Global Market for Pain Management, by Region, 2014-2022 ($ Millions)
  • Figure 29 Pain Management Drug Pipeline, by Development Status (Number)
  • Figure 30 Pain Management Drug Pipeline, by Primary Indication (Number)
  • Figure 31 Pain Management Devices in Development, by Development Status (%)
  • Figure 32 Shares of U.S. Patents on Pain Technologies, by Three-Year Date Range, Jan 2000-March 2017 (%)
  • Figure 33 Shares of U.S. Patents on Pain Technologies, by Abstract Description (%)
  • Figure 34 Patent Shares of Pain Technologies (%)
  • Figure 35 Global Market for Pain Management Pharmaceuticals, by Actual and Projected Brand vs. Generic Sales Performance, 2012-2022 ($ Millions)
  • Figure 36 Distribution of Pain-related Clinical Trials for All Ages, by Region, 2017 (%)
  • Figure 37 Distribution of Pain-related Clinical Trials for Pediatrics, by Region, 2017 (%)
  • Figure 38 Global Market for Pain Management, 2015-2022 ($ Millions)
  • Figure 39 Global Market for Pain Management, by Major Type, 2014-2022 ($ Millions)
  • Figure 40 Global Market for Pain Management, by Application, 2014-2022 ($ Millions)
  • Figure 41 Global Market for Pain Management, by Region, 2014-2022 ($ Millions)
Back to Top